NCT01411124View on ClinicalTrials.gov

Study to Assess the Effect of Gabapentin Enacarbil on Simulated Driving in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
Restless Legs Syndrome (RLS)
Interventions
DRUG

gabapentin enacarbil

600 mg investigational compound

DRUG

diphenhydramine

50 mg active comparator

DRUG

placebo

placebo

Trial Locations (1)

78744

GSK Investigational Site, Austin

All Listed Sponsors
lead

XenoPort, Inc.

INDUSTRY

NCT01411124 - Study to Assess the Effect of Gabapentin Enacarbil on Simulated Driving in Healthy Subjects | Biotech Hunter | Biotech Hunter